Binding profile of benextramine at neuropeptide Y receptor subtypes in rat brain areas

Eur J Pharmacol. 1994 Nov 14;265(1-2):93-8. doi: 10.1016/0014-2999(94)90228-3.

Abstract

Binding studies in rat whole brain, frontoparietal cortex and brainstem membrane preparations revealed that benextramine displaced [3H]neuropeptide Y specific binding from a low and a high affinity site with IC50 values in the microM (36 +/- 2, 4.4 +/- 1.4 and 300 +/- 120 microM, respectively) and the pM (29.3 +/- 12.1, 0.35 +/- 0.11 and 0.42 +/- 0.03 pM, respectively) range, whereas in rat hippocampus benextramine displaced [3H]neuropeptide Y specific binding from one site only with an IC50 value of 22.8 +/- 5.7 microM. With the exception of frontoparietal cortex binding assay, benextramine was not able to completely inhibit [3H]neuropeptide Y specific binding revealing the presence of a benextramine nonsensitive third binding site. Benextramine pretreatment followed by membrane washing demonstrated that benextramine inhibited irreversibly both high and low affinity sites.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic alpha-Antagonists / metabolism*
  • Adrenergic alpha-Antagonists / pharmacology
  • Animals
  • Binding, Competitive
  • Brain / drug effects
  • Brain / metabolism*
  • Brain Stem / drug effects
  • Brain Stem / metabolism
  • Computer Simulation
  • Cystamine / analogs & derivatives*
  • Cystamine / metabolism
  • Cystamine / pharmacology
  • Diamines / metabolism
  • Diamines / pharmacology
  • Frontal Lobe / drug effects
  • Frontal Lobe / metabolism
  • Hippocampus / drug effects
  • Hippocampus / metabolism
  • Male
  • Parietal Lobe / drug effects
  • Parietal Lobe / metabolism
  • Radioligand Assay
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Neuropeptide Y / drug effects
  • Receptors, Neuropeptide Y / metabolism*

Substances

  • Adrenergic alpha-Antagonists
  • Diamines
  • Receptors, Neuropeptide Y
  • CM 178-78
  • benextramine
  • Cystamine